ClinConnect ClinConnect Logo
Search / Trial NCT03933280

Conscious Sedation for Cataract Operations Under Topical Anaesthesia

Launched by MENOUFIA UNIVERSITY · Apr 30, 2019

Trial Information

Current as of September 14, 2025

Completed

Keywords

ClinConnect Summary

In both groups, the patients will receive i.v. nalbuphine 50 μg/kg. Patients in group D, will receive an i.v. loading dose of dexmedetomidine 1 μg/kg over 10 min followed by a maintenance infusion of 0.5 μg/kg/h. Patients in group P, will receive a bolus i.v. dose of propofol 0.5 mg/kg followed by an infusion started at 0.025 mg/kg/min .If sedation score was \<3, rescue sedation with boluses of midazolam 0.01 mg/kg will be given. If the patient complained of pain (Numerical verbal pain rating scale ≥3) during the surgery, i.v. fentanyl 50 μg will be given as an intra-operative rescue analge...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Both genders,
  • 20 and 65 years,
  • American Society of Anesthesiologists (ASA) physical status I and II,
  • Scheduled for cataract extraction surgery under topical anaesthesia.
  • Exclusion Criteria:
  • Known allergy to local anaesthetics,
  • Allergy to study drugs,
  • Second or third-degree heart block,
  • Alcohol or drug abuse
  • Morbid obesity, pregnant and lactating females,
  • Patients with severe cardiac, renal and hepatic disorders.

About Menoufia University

Menoufia University is a prominent educational and research institution located in Egypt, dedicated to advancing medical science and improving healthcare outcomes through innovative clinical research. The university's clinical trial sponsorship is characterized by a commitment to ethical standards, rigorous scientific methodology, and collaboration with multidisciplinary teams. By leveraging its academic resources and expertise, Menoufia University aims to contribute to the development of new therapies and interventions, ultimately enhancing patient care and public health within the region and beyond.

Locations

Cairo, Shebin El Kom, Egypt

Patients applied

0 patients applied

Trial Officials

Abd-Elazeem A Elbakry, MD

Principal Investigator

Associate professor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials